Caroline Vandeputte

Author PubWeight™ 8.18^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Highly efficient multicistronic lentiviral vectors with peptide 2A sequences.	Hum Gene Ther	2009	1.54
2	Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.	BMC Cancer	2013	1.43
3	Effects of MRI contrast agents on the stem cell phenotype.	Cell Transplant	2010	1.13
4	Mapping of oxygen by imaging lipids relaxation enhancement: a potential sensitive endogenous MRI contrast to map variations in tissue oxygenation.	Magn Reson Med	2012	0.93
5	Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer.	Nucl Med Biol	2011	0.87
6	Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging.	Bioorg Med Chem	2011	0.83
7	Ras in digestive oncology: from molecular biology to clinical implications.	Curr Opin Oncol	2014	0.77
8	Tackling immunomonitoring in gastrointestinal cancer.	Curr Opin Oncol	2017	0.76
9	Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN study.	BMC Cancer	2014	0.75
10	In times of crisis, go liquid!	Curr Opin Oncol	2014	0.75